EN
抗体药类似物
Research Grade Cibisatamab
All
TD-HY546036_1.jpg
TD-HY546036_2.jpg
TD-HY546036_3.jpg
  • CatalogTD-HY546036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,CEATCB,RG-7802,RO-6958688,CAS:2101242-53-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Cibisatamab


Catalog No. TD-HY546036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa/lambdawithdomaincrossover
Expression system Mammalian Cells
Clonality Monoclonal
Target Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P06731 & P07766
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,CEATCB,RG-7802,RO-6958688,CAS:2101242-53-7
Background Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY546036_1.jpg
Bioactivity
 
Detects Human CD66e/CEA/CEACAM5 & CD3E separately in indirect ELISAs.
TD-HY546036_2.jpg
Bioactivity
 
Detects Human CD66e/CEA/CEACAM5 & CD3E separately in indirect ELISAs.
TD-HY546036_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Cibisatamab.